5 Stocks Yielding 5X the Nasdaq-100 to Buy in November

The article highlights five consumer-staples stocks yielding 3.4%–5.8%, versus roughly 0.6% for the Nasdaq-100, as potential income diversifiers. Kimberly-Clark completed its Kenvue acquisition on Nov. 2, funded partly by $4.9 billion of senior notes, while Hershey reported Q3 sales up 3% to $3.28 billion and adjusted gross margin of 42.7%. J.M. Smucker raised its outlook, Nomad Foods lifted its 2026 organic revenue outlook, and Molson Coors faces falling beer volumes and previously guided to an 11%–15% decline in 2026 earnings; the article stresses that higher yields carry company-specific risks.

Analysis

The yield comparison is a weak investment thesis on its own: these stocks carry different operating and balance-sheet risks, and a high payout can coexist with falling earnings and a shrinking valuation. The cleaner relative-value distinction is cyclical cost relief versus structural volume pressure. HSY’s margin recovery can translate into earnings leverage if cocoa costs normalize and holiday sell-through holds; TAP needs evidence that pricing, mix, or adjacent brands can offset beer-volume declines. Buybacks may support TAP’s per-share figures while total business economics deteriorate.

Over the next 1–3 months, prioritize reported cash conversion and underlying operating trends over headline EPS. For SJM, strip out the tariff refund before judging whether guidance improvement is durable. For KMB, the acquisition adds integration and financing execution risk: the key test is whether realized synergies and cash generation reduce leverage without weakening investment in the legacy business. NOMD’s productivity savings are not a substitute for stabilizing volumes if European retailers continue shifting shoppers to private label.

Contrarian point: staples are not automatically defensive when debt costs, input inflation, or retailer bargaining power absorb the apparent yield advantage. A selective staples allocation may diversify a growth-heavy book, but the article provides no valuation or payout-coverage comparison to justify buying all five. The main reversal risks are renewed cocoa inflation, failed KMB integration or slower deleveraging, persistent beer declines, and NOMD’s growth outlook failing to convert into cash flow.

Key Decisions for Investors

• Consider a modest HSY-long/TAP-short relative-value position rather than buying both yields indiscriminately. Reassess after holiday demand and the next earnings updates: the thesis is improving confection margins versus unresolved beer-volume erosion. Risk: cocoa re-inflation or TAP showing sustained volume stabilization; reduce or exit if those operating trends reverse.
• Keep KMB on a post-close watchlist rather than adding solely for its yield. Before sizing, verify pro forma leverage, interest expense, cash conversion, integration costs, and realized—not merely targeted—synergies in upcoming disclosures. Slower deleveraging or weaker guidance falsifies the prospective defensive thesis.
• Treat SJM’s raised outlook as provisional until results exclude the tariff refund and show recurring free-cash-flow coverage of the dividend. Track organic volume, pricing, and cash generation; do not extrapolate adjusted EPS that includes a one-off benefit.
• For NOMD, require evidence that organic growth and productivity savings appear in cash flow, not just targets. Watch retailer/private-label pressure and currency effects; absent volume stabilization, the elevated yield is a warning rather than a catalyst.
• Avoid using dividend yield alone to rotate out of Nasdaq-100 exposure. If adding staples, size against portfolio rate sensitivity and compare total-return valuation and payout coverage; the article does not establish that these names are cheaper or safer on those measures.